CFO Ernesto Flores Resigns Abruptly; CEO Saumat Takes Over Finance on Interim Basis
Summary
Earth Science Tech's CFO and director Ernesto Flores resigned effective October 25, 2026, with CEO Giorgio Saumat taking over as principal financial and accounting officer on an interim basis while Flores consults on the pending 10-Q.
Key Events · Executive and Board Changes · ETST
-
CFO and Director Resigns Same Day
Ernesto L. Flores resigned as Chief Financial Officer and as a member of the Board of Directors effective October 25, 2026, and also left the Board's Compensation Committee.
-
CEO Adds Finance and Accounting Roles
Effective October 25, 2026, CEO Giorgio R. Saumat serves as principal financial officer and principal accounting officer on an interim basis until a successor is appointed.
-
No Disagreement Stated; Consultant Role
The filing states the resignation was not the result of any disagreement over operations, policies or practices, and Flores will remain available as a consultant to help complete the auditor's review and file the Form 10-Q for the quarter ended September 30, 2026.
-
Timing Ahead of Quarterly Filing
The departure lands during the auditor's review of the September 30, 2026 quarter, leaving the CEO as sole principal financial and accounting officer through that filing.
Analysis · ETST · Life Sciences
The CFO and a board member left on the same day, and the CEO now also serves as principal financial officer and principal accounting officer. That concentrates a lot of financial-reporting responsibility in one person at a company that just completed two related-party acquisitions and is heading into an auditor's review of the September 30 quarter. The filing says there was no disagreement, and Flores is staying on as a consultant to help finish the 10-Q, which softens the blow — but a same-day exit of the top finance officer is rarely a neutral event for a micro-cap trading on the OTCQB.
How filings like this one have moved
In the 30 days to Oct 26, 2026, 29.9% of the 1374 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ETST was trading at $0.09 on OTC in the Life Sciences sector, with a market capitalization of approximately $27.2M. The 52-week trading range was $0.00 to $0.24. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.